Company intelligence / Profile preview

Asian Alliance Radiation & Oncology

Singapore, Singaporeaaro.sg ↗

Ownership: Private
Development stage: Commercial

Overview

AARO operates as a leading independent radiotherapy and oncology specialist group in Singapore. It provides advanced radiation therapies such as Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) for a wide range of solid tumors. The company’s clinical team pioneered these techniques regionally and continues to offer comprehensive oncology care from diagnosis through survivorship. No drug development or clinical trial pipeline; all services are commercialized.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalDevice (radiation therapy equipment)Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

University of Pittsburgh Medical Center (UPMC)MD Anderson Cancer Center

Beyond the preview

Go deeper on Asian Alliance Radiation & Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asian Alliance Radiation & Oncology.

Explore the full profile